Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort

PURPOSE: Ipilimumab improves survival in advanced melanoma patients. However, the efficacy and safety of ipilimumab has not been evaluated in Asian melanoma patients with a high frequency of mucosal and acral melanoma subtypes. MATERIALS AND METHODS: Advanced melanoma patients treated with 3 mg/kg i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Minkyu, Lee, Jeeyun, Kim, Tae Min, Lee, Dae Ho, Kang, Jin Hyung, Oh, Sung Young, Lee, Soo Jung, Shin, Sang Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266404/
https://www.ncbi.nlm.nih.gov/pubmed/27121719
http://dx.doi.org/10.4143/crt.2016.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266404/
https://www.ncbi.nlm.nih.gov/pubmed/27121719
http://dx.doi.org/10.4143/crt.2016.024

Ejemplares similares